Original language | English (US) |
---|---|
Article number | 89 |
Journal | Blood cancer journal |
Volume | 12 |
Issue number | 6 |
DOIs | |
State | Published - Jun 2022 |
Bibliographical note
Funding Information:MH, GG, JA, AAA, GJR, JRY, AR, NNB, MVS, JHR, CJD, MJK, WOT, JCS, KLR, RSG—none. RV—research funding from Pfizer, Bristol Myers Squibb, and Sun Pharmaceuticals. is available at Blood Cancer Journal’s website.
Funding Information:
This study was supported by the University of Iowa/Mayo Clinic Lymphoma SPORE CA97274, the University of Minnesota T32 Hematology Research Training Program Grant 2T32HL007062 (M.H.), and the Walter B. Frommeyer, Jr., Fellowship Award in Investigative Medicine, University of Alabama at Birmingham (G.G.). The study was partly presented in abstract form at the 2019 American Society of Hematology annual meeting in Orlando, Florida.